Hosted on MSN
DiamiR Biosciences Gains New York State Approval for APOE Genotyping Test, Expanding Alzheimer’s Risk Screening
DiamiR Biosciences Corp., a developer of blood-based diagnostics for brain health, and Aptorum Group Limited (NASDAQ:APM), a clinical-stage biopharmaceutical firm, announced that New York State’s ...
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and ...
Revvity, Inc., announced today the launch of the in-vitro diagnostic EURORealTime ™ APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results